Karyopharm Therapeutics Inc.
Ticker: 1503802
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 33.43-4.7% | 35.07-20.4% | 44.04+16.1% | 37.93+26.3% | 30.02-22.6% | 38.78-9.4% | 42.79+29.2% | 33.13 |
| Total Income | 33.43-4.7% | 35.07-20.4% | 44.04+16.1% | 37.93+26.3% | 30.02-22.6% | 38.78-9.4% | 42.79+29.2% | 33.13 |
| EXPENSES | ||||||||
| Expenditure | 55.96-9.5% | 61.83+4.3% | 59.26-4.9% | 62.32-1.5% | 63.27-2.8% | 65.07-8.2% | 70.91+6.0% | 66.89 |
| Tax | 0.00 | 0.00-100.0% | 0.03-25.0% | 0.04+0.0% | 0.04+33.3% | 0.03-57.1% | 0.07+0.0% | 0.07 |
| PROFIT | ||||||||
| PBT | -67.02-199.3% | -22.39+32.3% | -33.09+11.1% | -37.21-58.8% | -23.43+26.9% | -32.04-234.3% | 23.86+164.0% | -37.29 |
| Net Profit | -67.02-199.3% | -22.39+32.4% | -33.13+11.1% | -37.25-58.8% | -23.46+26.8% | -32.07-234.8% | 23.79+163.7% | -37.36 |
| KEY METRICS | ||||||||
| OPM % | -67.38%+8.93pp | -76.31%-41.76pp | -34.56%+29.74pp | -64.30%+35.70pp | -100.00%-32.23pp | -67.77%-2.05pp | -65.72%+34.28pp | -100.00% |
| NPM % | -100.00%-36.14pp | -63.86%+11.36pp | -75.21%+23.00pp | -98.22%-20.05pp | -78.17%+4.53pp | -82.70%-138.30pp | 55.61%+155.61pp | -100.00% |
| EPS | -2.32-127.5% | -1.02+73.3% | -3.82+11.6% | -4.32-56.0% | -2.77-965.4% | -0.26-273.3% | 0.15+146.9% | -0.32 |
Corporate Events
Board MeetingKPTI
202613Jul
Board Meeting
Implementation of the 2026 Leadership Cash Retention Program…
SEC Filing ↗ Board MeetingKPTI
202621May
Board Meeting
Karyopharm Therapeutics Inc. held its 2026 Annual Meeting of…
SEC Filing ↗